Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 247 of 1,261
  1. US 11407764

    AhR modulators

    IDEAYA Biosciences, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  2. US 11407759

    Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

    ACTUATE THERAPEUTICS INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  3. US 11407820

    Modulating the alternative complement pathway

    The Regents of the University of Colorado · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  4. US 11407800

    Translatable molecules and synthesis thereof

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  5. US 11407736

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  6. US 11407747

    Compositions and methods for inhibiting kinases

    Inhibikase Therapeutics, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  7. US 11407752

    Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3′-indoline]-2′,5(3H)-dione analogues

    The Board of Regents of the University of Texas System · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  8. US 11407748

    Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function

    Takeda Pharmaceutical Company Limited · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  9. US 11407712

    Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α

    Arcus Biosciences, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  10. US 11407649

    Cerium (III) carbonate formulations

    The Regents of the University of California · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  11. US 11406724

    Stabilized radiolabeled anti-CD45 immunoglobulin compositions

    Actinium Phamaceuticals, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  12. US 11407705

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  13. US 11406722

    Nanodroplets with improved properties

    The Board of Regents of the University of Texas System · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  14. US 11406721

    Compositions and methods for imaging cell populations

    The Regents of the University of California · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  15. US 11406720

    Fibroblast growth factor receptor 2-specific peptide reagents and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  16. US 11406690

    Adeno-associated virus factor VIII vectors

    BIOMARIN PHARMACEUTICAL INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  17. US 11406710

    Constrained conditionally activated binding proteins

    Takeda Pharmaceutical Company Limited · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  18. US 11406663

    Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use

    UNICYCIVE THERAPEUTICS, INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  19. US 11406697

    Methods and compositions for treating glioma and medulloblastoma brain tumors using the zika virus

    Regents of the University of Minnesota · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  20. US 11406643

    Targeting kinases for the treatment of cancer metastasis

    The Board of Regents of the University of Texas System · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  21. US 11406616

    Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement

    SunRegen Healthcare AG · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  22. US 11406597

    Fusogenic liposome-coated porous silicon nanoparticles

    The Regents of the University of California · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  23. US 11407753

    Compounds for treating Huntington's disease

    PTC THERAPEUTICS, INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  24. CA 3206564

    PROCEDES ET COMPOSITIONS NUTRITIONNELLES PERMETTANT D'AMELIORER LA PRODUCTION D'ENERGIE MUSCULAIRE ET/OU LA FORCE MUSCULAIRE

    ABBOTT LAB [US] · Granted Aug 4, 2022 · Expires Jul 30, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.